Does REVATIO Cause Chronic obstructive pulmonary disease? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Chronic obstructive pulmonary disease have been filed in association with REVATIO. This represents 2.1% of all adverse event reports for REVATIO.
9
Reports of Chronic obstructive pulmonary disease with REVATIO
2.1%
of all REVATIO reports
5
Deaths
1
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From REVATIO?
Of the 9 reports, 5 (55.6%) resulted in death, 1 (11.1%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVATIO. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does REVATIO Cause?
Death (79)
Pulmonary hypertension (44)
Dyspnoea (41)
Cardiac failure (26)
Fall (21)
Pneumonia (20)
Malaise (17)
Cardiac disorder (14)
Respiratory failure (13)
Fluid retention (11)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which REVATIO Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
REVATIO vs REVEFENACIN
REVATIO vs REVLIMID
REVATIO vs REVOLADE
REVATIO vs REVUMENIB
REVATIO vs REYATAZ